Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Construction in Progress (2017 - 2022)

Marimed (MRMD) has disclosed Construction in Progress for 6 consecutive years, with $3.6 million as the latest value for Q1 2022.

  • On a quarterly basis, Construction in Progress fell 24.27% to $3.6 million in Q1 2022 year-over-year; TTM through Mar 2022 was $3.6 million, a 24.27% decrease, with the full-year FY2021 number at $10.6 million, up 236.49% from a year prior.
  • Construction in Progress was $3.6 million for Q1 2022 at Marimed, down from $10.6 million in the prior quarter.
  • In the past five years, Construction in Progress ranged from a high of $12.2 million in Q4 2018 to a low of $1.1 million in Q1 2019.
  • A 5-year average of $5.5 million and a median of $3.6 million in 2022 define the central range for Construction in Progress.
  • Peak YoY movement for Construction in Progress: tumbled 77.05% in 2019, then soared 236.49% in 2021.
  • Marimed's Construction in Progress stood at $12.2 million in 2018, then crashed by 77.05% to $2.8 million in 2019, then grew by 12.18% to $3.1 million in 2020, then skyrocketed by 236.49% to $10.6 million in 2021, then tumbled by 65.61% to $3.6 million in 2022.
  • Per Business Quant, the three most recent readings for MRMD's Construction in Progress are $3.6 million (Q1 2022), $10.6 million (Q4 2021), and $8.9 million (Q3 2021).